Skip to main content

Issuer news 16737


02/29/2024 10:39 – Inside information

Double-digit growth in 2023 resulted in twice the amount of business compared to 2018 and confirmed the status of the largest domestically owned pharmaceutical company.

Download document

02/29/2024 08:52 – Notification of the acquisition or disposal of own shares (art. 474. CMA) - Acquisition of shares

Download document

02/29/2024 08:19 – Other information

Download document